Evidence of Distinct Tumour-Propagating Cell Populations with Different Properties in Primary Human Hepatocellular Carcinoma

Background and Aims Increasing evidence that a number of malignancies are characterised by tumour cell heterogeneity has recently been published, but there is still a lack of data concerning liver cancers. The aim of this study was to investigate and characterise tumour-propagating cell (TPC) compartments within human hepatocellular carcinoma (HCC). Methods After long-term culture, we identified three morphologically different tumour cell populations in a single HCC specimen, and extensively characterised them by means of flow cytometry, fluorescence microscopy, karyotyping and microarray analyses, single cell cloning, and xenotransplantation in NOD/SCID/IL2Rγ−/− mice. Results The primary cell populations (hcc-1, -2 and -3) and two clones generated by means of limiting dilutions from hcc-1 (clone-1/7 and -1/8) differently expressed a number of tumour-associated stem cell markers, including EpCAM, CD49f, CD44, CD133, CD56, Thy-1, ALDH and CK19, and also showed different doubling times, drug resistance and tumorigenic potential. Moreover, we found that ALDH expression, in combination with CD44 or Thy-1 negativity or CD56 positivity identified subpopulations with a higher clonogenic potential within hcc-1, hcc-2 and hcc-3 primary cell populations, respectively. Karyotyping revealed the clonal evolution of the cell populations and clones within the primary tumour. Importantly, the primary tumour cell population with the greatest tumorigenic potential and drug resistance showed more chromosomal alterations than the others and contained clones with epithelial and mesenchymal features. Conclusions Individual HCCs can harbor different self-renewing tumorigenic cell types expressing a variety of morphological and phenotypical markers, karyotypic evolution and different gene expression profiles. This suggests that the models of hepatic carcinogenesis should take into account TPC heterogeneity due to intratumour clonal evolution.

[1]  Jane E. Visvader,et al.  Cells of origin in cancer , 2011, Nature.

[2]  F. Bertolini,et al.  Sex-related efficiency in NSG mouse engraftment. , 2010, Blood.

[3]  S. Thorgeirsson,et al.  Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications. , 2010, Journal of hepatology.

[4]  J. Settleman,et al.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer , 2010, Oncogene.

[5]  O. Heidenreich,et al.  Understanding the cancer stem cell , 2010, British Journal of Cancer.

[6]  Michel Salzet,et al.  Epithelial-mesenchymal transition in ovarian cancer. , 2010, Cancer letters.

[7]  Serban Nacu,et al.  A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. , 2010, Cancer cell.

[8]  M. Greaves.  Cancer stem cells: back to Darwin? , 2010, Seminars in cancer biology.

[9]  R. Lahesmaa,et al.  High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity , 2010, Nature Biotechnology.

[10]  C. Maley,et al.  The role of genetic diversity in cancer. , 2010, The Journal of clinical investigation.

[11]  M. Gönen,et al.  Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. , 2010, The Journal of clinical investigation.

[12]  J. Llovet,et al.  Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy. , 2010, Annual review of medicine.

[13]  V. Mazzaferro,et al.  Simultaneous characterization of progenitor cell compartments in adult human liver , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[14]  D. Zelterman,et al.  Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity. , 2009, Cancer research.

[15]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[16]  R. Eferl,et al.  Hepatic tumor–stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge , 2009, Oncogene.

[17]  S. Morrison,et al.  Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.

[18]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[19]  G. Maira,et al.  Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution , 2009, Oncogene.

[20]  F. Mosca,et al.  Establishment and Characterization of 4 New Human Pancreatic Cancer Cell Lines: Evidences of Different Tumor Phenotypes , 2009, Pancreas.

[21]  Hiroyuki Aburatani,et al.  Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis , 2009, Hepatology.

[22]  Kenji Ikeda,et al.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma. , 2008, The New England journal of medicine.

[23]  G. Pruneri,et al.  Human acute leukemia cells injected in NOD/LtSz‐scid/IL‐2Rγ null mice generate a faster and more efficient disease compared to other NOD/scid‐related strains , 2008, International journal of cancer.

[24]  Jiang Zhu,et al.  Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials , 2008, Journal of Cancer Research and Clinical Oncology.

[25]  G. Mazzini,et al.  Karyotype analysis of the euploid cell population of a mouse embryonic stem cell line revealed a high incidence of chromosome abnormalities that varied during culture , 2008, Cytogenetic and Genome Research.

[26]  T. Roskams,et al.  Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development , 2007, Hepatology.

[27]  G. Demetri,et al.  Molecular basis for sunitinib efficacy and future clinical development , 2007, Nature Reviews Drug Discovery.

[28]  Michael F. Clarke,et al.  Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.

[29]  I. Ng,et al.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells. , 2007, Gastroenterology.

[30]  S. Bicciato,et al.  Integrative genomic analysis reveals distinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myeloma. , 2007, Haematologica.

[31]  Takahiro Kunisada,et al.  Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. , 2006, Biochemical and biophysical research communications.

[32]  S. Wilhelm,et al.  Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. , 2006, Cancer research.

[33]  C. Maley,et al.  Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .

[34]  D. Steinemann,et al.  Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[35]  Tetsuhiro Chiba,et al.  Side population purified from hepatocellular carcinoma cells harbors cancer stem cell–like properties , 2006, Hepatology.

[36]  X. Guan,et al.  Cytogenetic and molecular genetic alterations in hepatocellular carcinoma , 2005, Acta Pharmacologica Sinica.

[37]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[38]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[40]  N. Wong,et al.  A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping , 2000, Hepatology.

[41]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[42]  D. Bigner,et al.  Chromosomal progression of malignant human gliomas from biopsy to establishment as permanent lines in vitro. , 1987, Cancer genetics and cytogenetics.